Skip to main content

MoneyWorks4Me

Jubilant Pharmova informs about disclosure

20 Jul 2024 Evaluate
Jubilant Pharmova has informed that it enclosed a communication pursuant to Provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company has received communication from USFDA at 01:44 am (IST) on July 19, 2024. The above mentioned document will be simultaneously posted on the Company's website at www.jubilantpharmova.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..